May 28, 2026 01:00 ET | Source: argenx SE May 28, 2026Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX),…
Sanofi’s venglustat accepted for priority review in the US to treat type 3 Gaucher disease Paris, May 28, 2026. The…
New York, NY, May 27, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated by the Food and Drug…
IRVINE, Calif., May 27, 2026 (GLOBE NEWSWIRE) -- Lantronix Inc. (Nasdaq: LTRX), a global provider of Edge AI and Industrial…
TAIPEI, Taiwan, May 27, 2026 (GLOBE NEWSWIRE) -- Wevr, a creative technology studio pioneering shared immersive experiences, today announced the…
May 27, 2026 07:00 ET | Source: Intchains Group Limited SINGAPORE, May 27, 2026 (GLOBE NEWSWIRE) -- Intchains Group Limited…
Antwerp, Belgium, May 27, 2026 – Agomab Therapeutics NV (Nasdaq: AGMB) (“Agomab”), a clinical-stage biopharmaceutical company focused on fibro-inflammation, today…
Collaboration combines Bonito’s proprietary functional delivery data engine and ligand discovery platform with DaltonTx’s adaptive AI technology to accelerate precision…
Press release – No. 10 / 2026 Zealand Pharma to Present Data atthe American Diabetes Association's 2026 Scientific Sessions Late-breaking…
CAMBRIDGE, Mass., May 26, 2026 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company developing transformative…